Kunming Longjin Pharmaceutical Co Ltd (002750) - Cash Flow Conversion Efficiency

Latest as of September 2023: -0.011x

Based on the latest financial reports, Kunming Longjin Pharmaceutical Co Ltd (002750) has a cash flow conversion efficiency ratio of -0.011x as of September 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-6.69 Million ≈ $-978.60K USD) by net assets (CN¥582.16 Million ≈ $85.19 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Kunming Longjin Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2024)

This chart illustrates how Kunming Longjin Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 002750 current and long-term liabilities for a breakdown of total debt and financial obligations.

Kunming Longjin Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Kunming Longjin Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
DL Holdings Co Ltd Preferred KO:000215	0.026x
K-Tech Solutions Company Limited Class A Ordinary Shares NASDAQ:KMRK	N/A
Systech Bhd KLSE:0050	-0.104x
Carnavale Resources Ltd AU:CAV	-0.018x
Transmetro Corporation Ltd AU:TCO	0.134x
Hudson Global Inc NASDAQ:HSON	0.003x
SBH Marine Holdings Berhad KLSE:0300	-0.001x
RS GROUP PLC LSE:RS1	0.087x

Annual Cash Flow Conversion Efficiency for Kunming Longjin Pharmaceutical Co Ltd (2011–2024)

The table below shows the annual cash flow conversion efficiency of Kunming Longjin Pharmaceutical Co Ltd from 2011 to 2024. For the full company profile with market capitalisation and key ratios, see Kunming Longjin Pharmaceutical Co Ltd stock valuation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥494.21 Million ≈ $72.32 Million	CN¥-34.24 Million ≈ $-5.01 Million	-0.069x	+4.52%
2023-12-31	CN¥541.13 Million ≈ $79.18 Million	CN¥-39.26 Million ≈ $-5.75 Million	-0.073x	-203.80%
2022-12-31	CN¥604.77 Million ≈ $88.50 Million	CN¥-14.44 Million ≈ $-2.11 Million	-0.024x	-9.42%
2021-12-31	CN¥678.29 Million ≈ $99.26 Million	CN¥-14.80 Million ≈ $-2.17 Million	-0.022x	-126.96%
2020-12-31	CN¥704.71 Million ≈ $103.12 Million	CN¥-6.78 Million ≈ $-991.68K	-0.010x	-258.38%
2019-12-31	CN¥665.89 Million ≈ $97.44 Million	CN¥4.04 Million ≈ $591.66K	0.006x	-87.44%
2018-12-31	CN¥655.93 Million ≈ $95.98 Million	CN¥31.70 Million ≈ $4.64 Million	0.048x	-46.27%
2017-12-31	CN¥645.54 Million ≈ $94.46 Million	CN¥58.06 Million ≈ $8.50 Million	0.090x	-42.15%
2016-12-31	CN¥670.46 Million ≈ $98.11 Million	CN¥104.24 Million ≈ $15.25 Million	0.155x	+32.78%
2015-12-31	CN¥599.41 Million ≈ $87.71 Million	CN¥70.19 Million ≈ $10.27 Million	0.117x	-52.34%
2014-12-31	CN¥285.57 Million ≈ $41.79 Million	CN¥70.16 Million ≈ $10.27 Million	0.246x	-30.30%
2013-12-31	CN¥302.00 Million ≈ $44.19 Million	CN¥106.46 Million ≈ $15.58 Million	0.353x	-12.24%
2012-12-31	CN¥226.94 Million ≈ $33.21 Million	CN¥91.16 Million ≈ $13.34 Million	0.402x	-1.16%
2011-12-31	CN¥186.74 Million ≈ $27.33 Million	CN¥75.90 Million ≈ $11.11 Million	0.406x	--

About Kunming Longjin Pharmaceutical Co Ltd

SHE:002750 China Drug Manufacturers - Specialty & Generic

Market Cap

$34.58 Million

CN¥236.29 Million CNY

Market Cap Rank

#23220 Global

#4724 in China

Share Price

CN¥0.59

Change (1 day)

+3.51%

52-Week Range

CN¥0.57 - CN¥1.13

All Time High

CN¥25.99